trending Market Intelligence /marketintelligence/en/news-insights/trending/izKZM7Vn8i4aajHiuYZvNw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

OrthoPediatrics sells adult product offering business

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

OrthoPediatrics sells adult product offering business

OrthoPediatrics Corp. sold substantially all of the assets related to the adult product offering of Vilex In Tennessee Inc. to Squadron Capital LLC's affiliate Vilex LLC.

In exchange, Squadron Capital will reduce OrthoPediatrics' debt under a $30 million note by $25 million.

OrthoPediatrics, a medical device company that develops and sells implants and devices to treat children with orthopedic conditions, paid the remaining $5 million along with accrued interest at the time of completion of the deal Dec. 31, 2019, according to a Jan. 6 press release.

In addition, OrthoPediatrics granted Vilex license to manufacture and sell products using technology Orthex LLC's technology. Orthex is a subsidiary of Warsaw, Ind.-based OrthoPediatrics.

OrthoPediatrics has the right to use and sell certain intellectual property that Vilex acquired as part of the deal. The company acquired Vilex In Tennessee and Orthex in June 2019.

Stifel and Bingham Greenebaum Doll LLP were OrthoPediatrics' exclusive financial and legal advisers, respectively, for the deal.